The U.S. cannabidiol market should expect to see continued gains in the years ahead, according to Cowen.
What Happened
The CBD market could represent a $16-billion opportunity by 2025, according to a report issued Monday by a team of Cowen analysts.
The findings are based on a roughly 40-percent increase in consumer incidence with the average user spending $640 — or less than $2 per day — each year.
To generate its findings, Cowen convened 11 of its analysts in its consumer, health care, industrials and regulatory teams to analyze the market; 2,500 consumers were surveyed to determine the findings. The report noted a higher than expected amount of CBD consumption.
"We were surprised to see that nearly 7 percent of respondents in January 2019 reported using CBD as a supplement,” the report said. This was the first month of data and findings could fluctuate, Cowen said.
The Cannabis Capital Conference is coming back to Toronto April 17-18!
Hemp — and its non-psychoactive derivative CBD — were federally legalized with the signing of the Farm Bill in January, but CBD-infused food remains illegal in the eyes of the federal government.
Why It's Important
The analysts compared CBD to another craze: JUUL vapes.
“Indeed, to put the 6.9-percent incidence rate in context, that compares to JUUL use of 4.2 percent, and 19.6 percent of consumers that consider themselves a current tobacco user, per our survey.”
Much of Cowen's estimations are conservative, according to the research firm.
This includes a belief that CBD use will grow 10 percent among adults, totaling around 25 million consumers by 2025.
The conservatism extends to the $16-billion forecast itself, the analysts said: "We can envision a scenario where a consumer that uses a CBD tincture or capsule may also be inclined to convert his or her beauty regimen to include CBD (e.g., CBD infused beauty products), and/or use a topical for targeted relief as well."
What's Next
Dissecting the industry a bit more, Cowen said it anticipates health and wellness to lead the market, with nutraceuticals earning $6.4 billion and topicals generating another $4 million. Smaller markets like food, beverages, beauty and vapor are all expected to have sales between $1 billion and $2.5 billion in the same time frame, in the sell-side firm's view.
Related Links:
OTC Stock Life On Earth Surges Following CBD Beverage Announcement
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.